WO2007015257A3 - A process for the preparation of gemcitabine using novel intermediates - Google Patents

A process for the preparation of gemcitabine using novel intermediates Download PDF

Info

Publication number
WO2007015257A3
WO2007015257A3 PCT/IN2005/000256 IN2005000256W WO2007015257A3 WO 2007015257 A3 WO2007015257 A3 WO 2007015257A3 IN 2005000256 W IN2005000256 W IN 2005000256W WO 2007015257 A3 WO2007015257 A3 WO 2007015257A3
Authority
WO
WIPO (PCT)
Prior art keywords
gemcitabine
novel intermediates
preparation
purity
pharmaceutically acceptable
Prior art date
Application number
PCT/IN2005/000256
Other languages
French (fr)
Other versions
WO2007015257A2 (en
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy Dasari Muralidhara
Reddy Itiyala Srinivas
Original Assignee
Hetero Drugs Ltd
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy Dasari Muralidhara
Reddy Itiyala Srinivas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd, Reddy Bandi Parthasaradhi, Reddy Kura Rathnakar, Reddy Rapolu Raji, Reddy Dasari Muralidhara, Reddy Itiyala Srinivas filed Critical Hetero Drugs Ltd
Priority to PCT/IN2005/000256 priority Critical patent/WO2007015257A2/en
Priority to ARP050103954A priority patent/AR051374A1/en
Priority to PE2006000283A priority patent/PE20070315A1/en
Publication of WO2007015257A2 publication Critical patent/WO2007015257A2/en
Publication of WO2007015257A3 publication Critical patent/WO2007015257A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention provides a commercially viable process for preparing gemcitabine and its pharmaceutically acceptable acid addition salts thereof in high yield and purity using novel intermediates.
PCT/IN2005/000256 2005-08-04 2005-08-04 A process for the preparation of gemcitabine using novel intermediates WO2007015257A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/IN2005/000256 WO2007015257A2 (en) 2005-08-04 2005-08-04 A process for the preparation of gemcitabine using novel intermediates
ARP050103954A AR051374A1 (en) 2005-08-04 2005-09-21 GEMCITABIN PREPARATION PROCESS AND RELATED COMPOUNDS
PE2006000283A PE20070315A1 (en) 2005-08-04 2006-03-14 PROCEDURE FOR THE PREPARATION OF GEMCITABIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2005/000256 WO2007015257A2 (en) 2005-08-04 2005-08-04 A process for the preparation of gemcitabine using novel intermediates

Publications (2)

Publication Number Publication Date
WO2007015257A2 WO2007015257A2 (en) 2007-02-08
WO2007015257A3 true WO2007015257A3 (en) 2008-04-10

Family

ID=37600974

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2005/000256 WO2007015257A2 (en) 2005-08-04 2005-08-04 A process for the preparation of gemcitabine using novel intermediates

Country Status (3)

Country Link
AR (1) AR051374A1 (en)
PE (1) PE20070315A1 (en)
WO (1) WO2007015257A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007235210A1 (en) * 2006-02-06 2007-10-18 Dr. Reddy's Laboratories Ltd. Preparation of gemcitabine
CN102659884B (en) * 2012-04-23 2014-07-02 南京臣功制药股份有限公司 Gemcitabine hydrochloride purifying method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2136425A (en) * 1983-03-10 1984-09-19 Lilly Co Eli Nucleosides
WO2004041203A2 (en) * 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2136425A (en) * 1983-03-10 1984-09-19 Lilly Co Eli Nucleosides
WO2004041203A2 (en) * 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 5, no. 7, 1995, pages 743 - 748 *
DATABASE CAPLUS [online] XIANG Y. ET AL.: "Synthesis and anti-HIV activities of 2'-deoxy-2',2"-difluoro-beta-L-ribofuranosyl-pyrimidine and -purine nucleosides", Database accession no. (1995:519328) *

Also Published As

Publication number Publication date
AR051374A1 (en) 2007-01-10
PE20070315A1 (en) 2007-06-06
WO2007015257A2 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
WO2009102155A3 (en) Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds
WO2008089984A3 (en) Process for the preparation of ezetimibe and derivatives thereof
WO2010076810A3 (en) A process for the preparation of gefitinib
WO2006071130A8 (en) A process for preparation of imatinib base
WO2009141718A3 (en) Process for the preparation of prostaglandin analogues and intermediates thereof
WO2008096372A3 (en) Process for preparing highly pure ezetimibe using novel intermediates
WO2010140765A2 (en) Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
TW200720246A (en) Novel process for the preparation of acid chlorides
EP2641897A3 (en) A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
WO2009083940A3 (en) Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
WO2011128784A3 (en) Novel process for preparing highly pure tapentadol or a pharmaceutically acceptable salt thereof
MX2009005664A (en) Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan.
WO2010026603A3 (en) Novel amine salts of tenofovir, process for producing the same and use thereof in production of tenofovir dioproxil
WO2012063126A3 (en) Improved processes for preparing pure (3ar,4s,6r,6as)-6-amino-2,2-dimethyltetrahdro-3ah-cyclopenta[d] [1,3]-dioxol-4-ol and its key starting material
WO2008117305A3 (en) A novel process for preparing pregabalin and its acid addition salts
WO2008087557A3 (en) An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride
WO2008035380A3 (en) An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
WO2006010620A3 (en) Olanzapine salts and their conversion to olanzapine free base
WO2009037538A3 (en) Process for the preparation of lamivudine form i
WO2012146978A3 (en) A novel process for the preparation of tapentadol or a pharmaceutically acceptable salt thereof
WO2008099286A3 (en) Improved process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2- piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide
WO2007054969A3 (en) Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
WO2008059513A3 (en) Compounds suitable as modulators of hdl
WO2009116072A3 (en) Process for preparation of pyridinylmethylsulphinyl benzimidazole compounds and pyridine intermediates
WO2009021943A3 (en) Novel preparation process

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 3961/CHENP/2006

Country of ref document: IN

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05788659

Country of ref document: EP

Kind code of ref document: A2